Please use this identifier to cite or link to this item: https://rfos.fon.bg.ac.rs/handle/123456789/603
Full metadata record
DC FieldValueLanguage
dc.creatorBožić, Biljana
dc.creatorLončar, Goran
dc.creatorProdanović, Nenad
dc.creatorRadojičić, Zoran
dc.creatorČvorović, Vojkan
dc.creatorDimković, Siniša
dc.creatorPopović-Brkić, Vera
dc.date.accessioned2023-05-12T10:13:26Z-
dc.date.available2023-05-12T10:13:26Z-
dc.date.issued2010
dc.identifier.issn1071-9164
dc.identifier.urihttps://rfos.fon.bg.ac.rs/handle/123456789/603-
dc.description.abstractBackground: The aim of the study was to investigate the associations of adiponectin and leptin to bone mass and bone specific surrogates in elderly males with chronic heart failure (CHF). Methods and Results: Seventy-three males (mean age 68 7 years) with stable mild to moderate CHF and 20 healthy individuals age- and body mass index matching underwent dual energy x-ray absorptiometry measurements (bone mineral density (BMD) at hip and lumbar spine, total bone mineral content, and body composition); echocardiography; 6-minute walk test; grip strength; and biochemical assessment including adiponectin, leptin, bone specific surrogates (osteocalcin, beta-CrossLaps, osteoprotegerin [OPG], receptor activator of nuclear factor kappa B ligand [RANKL]), parathyroid hormone, 25-hydroxy vitamin D, testosterone, sex hormone-binding globulin, and NT-pro-BNP. Serum adiponectin, osteocalcin, beta-CrossLaps, OPG, RANKL, and parathyroid hormone were significantly increased in CHF patients, whereas 25-hydroxy vitamin D was significantly lower compared to healthy controls. The significant positive association was found between adiponectin level with osteocalcin, beta-CrossLaps, OPG, and RANKL among CHF patients. In multivariate regression analysis, adiponectin was a significant determinant of total hip BMD, although the variance was small (r(2) = 0.239), whereas leptin was determinant for total bone mineral content (r(2) = 0.469) in patients with CHF. Conclusions: Serum adiponectin is an independent predictor of BMD in elderly males with mild to moderate CHF, and showed a positive correlation to bone specific surrogates. Adiponectin, as cardioprotective hormone, seems to be able to exert a negative effect on bone mass in chronic heart failure. Further research is needed to confirm the potential for adipokines in the crosstalk between bone and energy metabolism in CHF patients. (J Cardiac Fail 2010;16:301-307)en
dc.publisherChurchill Livingstone Inc Medical Publishers, Philadelphia
dc.relationinfo:eu-repo/grantAgreement/MESTD/MPN2006-2010/145019/RS//
dc.relationMerck Sharp Dohme
dc.relationbiochemical laboratory "Zavod za laboratorijsku dijagnostiku Konzilijum" Belgrade
dc.rightsrestrictedAccess
dc.sourceJournal of Cardiac Failure
dc.subjectleptinen
dc.subjectheart failureen
dc.subjectboneen
dc.subjectbone markersen
dc.subjectAdiponectinen
dc.titleRelationship Between High Circulating Adiponectin With Bone Mineral Density and Bone Metabolism in Elderly Males With Chronic Heart Failureen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage307
dc.citation.issue4
dc.citation.other16(4): 301-307
dc.citation.rankM22
dc.citation.spage301
dc.citation.volume16
dc.identifier.doi10.1016/j.cardfail.2009.12.015
dc.identifier.pmid20350696
dc.identifier.rcubconv_1249
dc.identifier.scopus2-s2.0-77950034070
dc.identifier.wos000277060400004
dc.type.versionpublishedVersion
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextrestricted-
item.openairetypearticle-
Appears in Collections:Radovi istraživača / Researchers’ publications
Files in This Item:
File Description SizeFormat 
599.pdf
  Restricted Access
181.99 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

40
checked on Nov 17, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.